Fmoc-L-Val-OSu

Fmoc-L-Val-OSu is an Fmoc-protected L-valine N-(9H-fluoren-9-ylmethoxycarbonyl) activated ester where the carboxylate is converted to an N-hydroxysuccinimide (OSu) ester, providing a stable, chiral amino acid derivative for amide-forming coupling chemistry. The L-configuration of the valine stereocenter preserves the side-chain stereochemical identity used in peptide and peptidomimetic synthesis, while the valine isopropyl side chain influences hydrophobicity and conformational preferences in the resulting amide products. The Fmoc carbamate and the OSu ester are orthogonal functional handles: the Fmoc group supports standard base-labile deprotection in peptide assembly, and the OSu ester undergoes nucleophilic acyl substitution to form peptide bonds with amines under mild conditions. The combination of a protected amino terminus and an activated carboxylate makes Fmoc-L-Val-OSu a practical intermediate for preparing peptide building blocks, generating amide-linked conjugates, and enabling downstream synthetic transformations in both research and manufacturing workflows.

1. Peptide Coupling Chemistry

Fmoc-L-Val-OSu is applied in peptide synthesis workflows where activated carboxylates are required for reliable amide bond formation to construct Val-containing sequences. The Fmoc-protected amino group provides compatibility with stepwise solid-phase or solution-phase strategies, while the OSu ester activates the valine carboxylate toward reaction with primary and secondary amines. The stereodefined L-valine center is retained through the activation and coupling steps, supporting stereochemical fidelity in peptide building block preparation and subsequent sequence assembly. The resulting amide products can serve as protected peptide fragments, enabling iterative elongation and facilitating the preparation of analog libraries for structure-activity relationship studies. Fmoc-L-Val-OSu therefore functions as a chiral, peptide-ready intermediate bridging amino acid activation and protected amino acid chemistry.

2. Bioconjugation And Protein Labeling

Fmoc-L-Val-OSu is suitable for chemical biology and bioconjugation applications that rely on controlled acylation of biomolecule amines to generate amide-linked adducts. The OSu ester reacts with lysine side-chain amines, N-termini, and other nucleophilic amine functionalities, while the Fmoc group can be used as a removable protecting handle when orthogonal deprotection is required for downstream processing. The valine-derived hydrophobic side chain can influence local microenvironments around the conjugation site, which may be relevant when generating labeled peptides or amide-linked linkers for analytical assays. Amide formation from the activated ester enables preparation of conjugation intermediates used in labeling strategies, affinity probes, and mapping reagents. Fmoc-L-Val-OSu thus supports amide-based biomolecule modification while maintaining a defined amino acid stereochemical identity.

3. Protected Amino Acid Intermediate

Fmoc-L-Val-OSu is employed as a protected amino acid intermediate for process chemistry intermediate preparation and fine chemical synthesis of Fmoc-protected peptide components. The Fmoc carbamate provides a stable N-protection strategy that can be removed under standard base conditions during peptide assembly, while the OSu ester allows conversion of the carboxyl group into an acylating species without requiring separate coupling reagent systems in many workflows. The orthogonality between the Fmoc group and the activated ester supports route design where activation and coupling can be staged, followed by deprotection at a later step. The defined L-valine stereochemistry and the clean transformation from amino acid to amide-forming intermediate can be integrated into manufacturing-oriented synthesis planning for protected peptide building blocks. Fmoc-L-Val-OSu therefore serves as a chiral, manufacturable intermediate connecting amino acid derivatization to protected amino acid synthesis.

4. Peptidomimetics And SAR Building Blocks

Fmoc-L-Val-OSu is applied in peptidomimetic construction and medicinal chemistry research where amide-linked scaffolds require incorporation of valine residues with stereochemical control. The activated OSu ester can couple to amine-containing fragments used in peptidomimetic linkers, while the Fmoc group supports compatibility with protected-fragment assembly and subsequent deprotection when assembling larger constructs. The valine side chain contributes hydrophobic character and can modulate conformational tendencies in the resulting amide framework, supporting rational design of analogs for structure-activity relationship studies. The ability to generate defined amide intermediates supports parallel synthesis of scaffold variants and downstream purification into characterization-ready materials. Fmoc-L-Val-OSu thus functions as a chiral amino acid derivative enabling SAR-focused peptidomimetic and fragment-based scaffold assembly.

5. Analytical Standards And Method Development

Fmoc-L-Val-OSu is useful in analytical research and method development where defined Fmoc-protected valine derivatives are required as standards or reference materials for monitoring derivatization and coupling performance. The presence of both Fmoc and an activated ester handle supports generation of predictable amide products under controlled conditions, enabling calibration and characterization of peptide coupling steps by chromatographic and spectrometric workflows. The stereochemically defined L-valine backbone helps ensure that reference materials reflect the stereochemical outcomes expected in peptide building block preparation. The OSu ester can also be used to generate labeled or derivatized amide species for method validation, including assessments of reagent reactivity and conversion profiles. Fmoc-L-Val-OSu therefore supports analytical method development tied to amino acid derivatization, protected amino acid chemistry, and peptide coupling monitoring.

1. Emu oil in combination with other active ingredients for treating skin imperfections

2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis